<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35352622</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>31</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1744-5116</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>60</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pharmaceutical biology</Title>
          <ISOAbbreviation>Pharm Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>β-Hydroxyisovalerylshikonin regulates macrophage polarization <i>via</i> the AMPK/Nrf2 pathway and ameliorates sepsis in mice.</ArticleTitle>
        <Pagination>
          <StartPage>729</StartPage>
          <EndPage>742</EndPage>
          <MedlinePgn>729-742</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13880209.2022.2046111</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="UNASSIGNED">The potential anti-inflammatory bioactivities of β-hydroxyisovalerylshikonin (β-HIVS) remain largely unknown.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study investigated the anti-inflammatory effects and underlying mechanisms of β-HIVS.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">RAW 264.7 cells stimulated with LPS (100 ng/mL) for 24 h were treated with the non-cytotoxic doses of β-HIVS (0.5 or 1 μM, determined by MTT and Trypan blue staining), qRT-PCR and FCM assay were used to examine macrophage polarization transitions. Western blotting was used to evaluate the activation of the AMPK/Nrf2 pathway. <i>In vivo</i>, C57BL/6 mice were randomly divided into vehicle control, LPS (10 mg/kg), and β-HIVS (2.5 mg/kg) combined with LPS (10 mg/kg) groups, blood samples, BALF, and lung tissues of mice were subjected to ELISA, qRT-PCR, FCM, and H&amp;E staining.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">β-HIVS (1 μM) inhibited LPS-induced expression of M1 macrophage markers (TNF-α: 0.29-fold, IL-1β: 0.32-fold), promoted the expression of M2 macrophage markers (CD206: 3.14-fold, Arginase-1: 3.98-fold) in RAW 264.7 cells; mechanistic studies showed that β-HIVS increased the expression of nuclear Nrf2 (2.04-fold) and p-AMPK (3.65-fold) compared with LPS group (<i>p</i> &lt; 0.05). <i>In vivo</i>, β-HIVS decreased the levels of pro-inflammatory cytokines (TNF-α: 1130.41 <i>vs.</i> 334.88 pg/mL, IL-1β: 601.89 <i>vs.</i> 258.21 pg/mL in serum; TNF-α: 893.07 <i>vs.</i> 418.21 pg/mL, IL-1β: 475.22 <i>vs.</i> 298.54 pg/mL in BALF), decreased the proportion of M1 macrophages (77.83 <i>vs.</i> 68.53%) and increased the proportion of M2 macrophages (13.55 <i>vs.</i> 19.56%) in BALF, and reduced lung tissue damage and septic mice survival (<i>p</i> &lt; 0.05).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">These results indicate that β-HIVS may be a new potential anti-inflammatory agent.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pan</LastName>
            <ForeName>Tao</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Translational Medicine Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shaanxi Key Laboratory of Brain Disorders, Institute of Basic Medical Sciences, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, Shaanxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Yabin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Translational Medicine Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Min</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Translational Medicine Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Zehui</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Translational Medicine Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Xinling</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Carson International Cancer Center, Shenzhen University, Shenzhen, Guangdong, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shenzhen University Clinical Medical Academy, Shenzhen, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pharm Biol</MedlineTA>
        <NlmUniqueID>9812552</NlmUniqueID>
        <ISSNLinking>1388-0209</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009285">Naphthoquinones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C118460">beta-hydroxyisovalerylshikonin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.31</RegistryNumber>
          <NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051267" MajorTopicYN="Y">NF-E2-Related Factor 2</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009285" MajorTopicYN="N">Naphthoquinones</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chinese herb extract</Keyword>
        <Keyword MajorTopicYN="N">anti-inflammatory effect</Keyword>
        <Keyword MajorTopicYN="N">lipopolysaccharide</Keyword>
        <Keyword MajorTopicYN="N">non‑cytotoxic dose</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>8</Hour>
          <Minute>39</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35352622</ArticleId>
        <ArticleId IdType="pmc">PMC8973340</ArticleId>
        <ArticleId IdType="doi">10.1080/13880209.2022.2046111</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Benoit M, Desnues B, Mege JL.. 
2008. Macrophage polarization in bacterial infections. J Immunol. 3733–3739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18768823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho HY, Gladwell W, Wang X, Chorley B, Bell D, Reddy SP, Kleeberger SR.. 
2010. Nrf2-regulated PPAR{γ} expression is critical to protection against acute lung injury in mice. Am J Respir Crit Care Med. 182(2):170–182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2913232</ArticleId>
            <ArticleId IdType="pubmed">20224069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al. . 
2013. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 41(2):580–637.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23353941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dilshara MG, Karunarathne WAHM, Molagoda IMN, Kang C-H, Jeong J-W, Choi YH, Kim G-Y.. 
2018. β-Hydroxyisovalerylshikonin promotes reactive oxygen species production in HCT116 colon cancer cells, leading to caspase-mediated apoptosis. Rev Brasil Farmacog. 28(3):344–351.</Citation>
        </Reference>
        <Reference>
          <Citation>Ding H, Wang JJ, Zhang XY, Yin L, Feng T.. 
2021. Lycium barbarum polysaccharide antagonizes LPS-induced inflammation by altering the glycolysis and differentiation of macrophages by triggering the degradation of PKM2. Biol Pharm Bull. 44(3):379–388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33390389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng L, Song P, Zhou H, Li A, Ma Y, Zhang X, Liu H, Xu G, Zhou Y, Wu X, et al. . 
2014. Pentamethoxyflavanone regulates macrophage polarization and ameliorates sepsis in mice. Biochem Pharmacol. 89(1):109–118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24607272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng LL, Xu LS, Guo MM, Huang W, Zhu JZ, Kong LD, Wu XD, Xu Q.. 
2019. 5,7,2′,4′,5′-Pentamethoxyflavanone regulates M1/M2 macrophage phenotype and protects the septic mice. Chin J Nat Med. 17(5):363–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31171271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu J, Zang Y, Zhou Y, Chen C, Shao S, Hu M, Shi G, Wu L, Zhang D, Zhang T.. 
2020. A novel triptolide derivative ZT01 exerts anti-inflammatory effects by targeting TAK1 to prevent macrophage polarization into pro-inflammatory phenotype. Biomed Pharmacother. 126:110084.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32171166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gordon S, Martinez FO.. 
2010. Alternative activation of macrophages: mechanism and functions. Immunity. 32(5):593–604.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20510870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grivennikov SI, Greten FR, Karin M.. 
2010. Immunity, inflammation, and cancer. Cell. 140(6):883–899.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2866629</ArticleId>
            <ArticleId IdType="pubmed">20303878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo Y, Zhang Y, Hong K, Luo F, Gu Q, Lu N, Bai A.. 
2014. AMPK inhibition blocks ROS-NFκB signaling and attenuates endotoxemia-induced liver injury. PLOS One. 9(1):e86881.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3901729</ArticleId>
            <ArticleId IdType="pubmed">24475189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hashimoto S, Xu M, Masuda Y, Aiuchi T, Nakajo S, Cao J, Miyakoshi M, Ida Y, Nakaya K.. 
1999. β-Hydroxyisovalerylshikonin inhibits the cell growth of various cancer cell lines and induces apoptosis in leukemia HL-60 cells through a mechanism different from those of Fas and etoposide. J Biochem. 125(1):17–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9880790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joo MS, Kim WD, Lee KY, Kim JH, Koo JH, Kim SG.. 
2016. AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550. Mol Cell Biol. 36(14):1931–1942.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4936058</ArticleId>
            <ArticleId IdType="pubmed">27161318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li P, Wu Y, Li M, Qiu X, Bai X, Zhao X.. 
2015. AS-703026 inhibits LPS-induced TNFα production through MEK/ERK dependent and independent mechanisms. PLOS One. 10(9):e0137107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4575053</ArticleId>
            <ArticleId IdType="pubmed">26381508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Niu X, Zhou W, Yi J.. 
2010. Growth inhibitory effect of β-hydroxyisovalerylshikonin on prostate cancer cells and related mechanism. J Shanghai Jiaotong Univ. 30:527–530.</Citation>
        </Reference>
        <Reference>
          <Citation>Livak KJ, Schmittgen TD.. 
2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt Method. Methods. 25(4):402–408.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11846609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu D, Qian J, Li W, Feng Q, Pan S, Zhang S.. 
2015. β-Hydroxyisovaleryl-shikonin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signaling. Oncol Lett. 10(6):3434–3442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4665374</ArticleId>
            <ArticleId IdType="pubmed">26788147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo W, Xu Q, Wang Q, Wu H, Hua J.. 
2017. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease. Sci Rep. 7:44612.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5353732</ArticleId>
            <ArticleId IdType="pubmed">28300213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lv H, Liu Q, Wen Z, Feng H, Deng X, Ci X.. 
2017. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis. Redox Biol. 12:311–324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5345976</ArticleId>
            <ArticleId IdType="pubmed">28285192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma WT, Gao F, Gu K, Chen DK.. 
2019. The role of monocytes and macrophages in autoimmune diseases: a comprehensive review. Front Immunol. 10:1140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6543461</ArticleId>
            <ArticleId IdType="pubmed">31178867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M.. 
2013. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 229(2):176–185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23096265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mantovani A, Sozzani S, Locati M, Allavena P, Sica A.. 
2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23(11):549–555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12401408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masuda Y, Nishida A, Hori K, Hirabayashi T, Kajimoto S, Nakajo S, Kondo T, Asaka M, Nakaya K.. 
2003. β-Hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1). Oncogene. 22(7):1012–1023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12592388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masuda Y, Shima G, Aiuchi T, Horie M, Hori K, Nakajo S, Kajimoto S, Shibayama-Imazu T, Nakaya K.. 
2004. Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. J Biol Chem. 279(41):42503–42515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15292218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo C, Wang L, Zhang J, Numazawa S, Tang H, Tang X, Han X, Li J, Yang M, Wang Z, et al. . 
2014. The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid Redox Signal. 20(4):574–588.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3901384</ArticleId>
            <ArticleId IdType="pubmed">23875776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan T, Zhang F, Li F, Gao X, Li Z, Li X, Ren X.. 
2020. Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway. Oncol Rep. 44(3):1049–1063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7388308</ArticleId>
            <ArticleId IdType="pubmed">32705271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan T, Zhang M, Zhang F, Yan G, Ru Y, Wang Q, Zhang Y, Wei X, Xu X, Shen L, et al. . 
2017. NDRG2 overexpression suppresses hepatoma cells survival during metabolic stress through disturbing the activation of fatty acid oxidation. Biochem Biophys Res Commun. 483(2):860–866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28069379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu YL, Cheng XN, Bai F, Fang LY, Hu HZ, Sun DQ.. 
2018. Aucubin protects against lipopolysaccharide-induced acute pulmonary injury through regulating Nrf2 and AMPK pathways. Biomed Pharmacother. 106:192–199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29958143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saccani A, Schioppa T, Porta C, Biswas SK, Nebuloni M, Vago L, Bottazzi B, Colombo MP, Mantovani A, Sica A.. 
2006. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 66(23):11432–11440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17145890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saha S, Buttari B, Panieri E, Profumo E, Saso L.. 
2020. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules. 25(22):5474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7700122</ArticleId>
            <ArticleId IdType="pubmed">33238435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneider CA, Rasband WS, Eliceiri KW.. 
2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 9(7):671–675.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5554542</ArticleId>
            <ArticleId IdType="pubmed">22930834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sica A, Mantovani A.. 
2012. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 122(3):787–795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3287223</ArticleId>
            <ArticleId IdType="pubmed">22378047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, Hainzl A, Schatz S, Qi Y, Schlecht A, et al. . 
2011. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest. 121(3):985–997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3049372</ArticleId>
            <ArticleId IdType="pubmed">21317534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takai N, Ueda T, Nishida M, Nasu K, Narahara H.. 
2010. Anti-neoplastic effect of β-hydroxyisovalerylshikonin on a human choriocarcinoma cell line. Mol Med Rep. 3(3):515–518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21472272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallmeyer L, Dietert K, Sochorová M, Gruber AD, Kleuser B, Vávrová K, Hedtrich S.. 
2017. TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents. Sci Rep. 7(1):774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5428778</ArticleId>
            <ArticleId IdType="pubmed">28377574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang R, Yin R, Zhou W, Xu D, Li S.. 
2012. Shikonin and its derivatives: a patent review. Expert Opin Ther Pat. 22(9):977–997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22834677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Huang Y, Xu Y, Ruan W, Wang H, Zhang Y, Saavedra JM, Zhang L, Huang Z, Pang T.. 
2018. A dual AMPK/Nrf2 activator reduces brain inflammation after stroke by enhancing microglia M2 polarization. Antioxid Redox Signal. 28(2):141–163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28747068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Xu Y, Zhang P, Ruan W, Zhang L, Yuan S, Pang T, Jia AQ.. 
2018. Smiglaside A ameliorates LPS-induced acute lung injury by modulating macrophage polarization via AMPK-PPARγ pathway. Biochem Pharmacol. 156:385–395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30195731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei J, Chen G, Shi X, Zhou H, Liu M, Chen Y, Feng D, Zhang P, Wu L, Lv X.. 
2018. Nrf2 activation protects against intratracheal LPS induced mouse/murine acute respiratory distress syndrome by regulating macrophage polarization. Biochem Biophys Res Commun. 500(3):790–796.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29684352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright CJ, Agboke F, Muthu M, Michaelis KA, Mundy MA, La P, Yang G, Dennery PA.. 
2012. Nuclear factor-κB (NF-κB) inhibitory protein IκBβ determines apoptotic cell death following exposure to oxidative stress. J Biol Chem. 287(9):6230–6239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3307281</ArticleId>
            <ArticleId IdType="pubmed">22223647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wynn TA, Chawla A, Pollard JW.. 
2013. Macrophage biology in development, homeostasis and disease. Nature. 496(7446):445–455.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3725458</ArticleId>
            <ArticleId IdType="pubmed">23619691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y, Kajimoto S, Nakajo S, Nakaya K.. 
2004. Beta-hydroxyisovalerylshikonin and cisplatin act synergistically to inhibit growth and to induce apoptosis of human lung cancer DMS114 cells via a tyrosine kinase-dependent pathway. Oncology. 66(1):67–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15031601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang F, Pan T, Wu X, Gao X, Li Z, Ren X.. 
2020. Non-cytotoxic doses of shikonin inhibit lipopolysaccharide-induced TNF-α expression via activation of the AMP-activated protein kinase signaling pathway. Exp Ther Med. 20(5):45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7480124</ArticleId>
            <ArticleId IdType="pubmed">32952636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang JL, Xu Y, Shen J.. 
2014. Cordycepin inhibits lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-α production via activating AMP-activated protein kinase (AMPK) signaling. Int J Mol Sci. 15(7):12119–12134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4139833</ArticleId>
            <ArticleId IdType="pubmed">25007068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang W, Zhang Y, He Y, Wang X, Fang Q.. 
2019. Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway. Exp Cell Res. 376(2):124–132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30763585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Shang F, Hui L, Zang K, Sun G.. 
2017. The alleviative effects of metformin for lipopolysaccharide-induced acute lung injury rat model and its underlying mechanism. Saudi Pharm J. 25(4):666–670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5447443</ArticleId>
            <ArticleId IdType="pubmed">28579909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou F, Wang M, Ju J, Wang Y, Liu Z, Zhao X, Yan Y, Yan S, Luo X, Fang Y.. 
2019. Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK/Nrf2 pathway regulation. Am J Transl Res. 11(1):199–209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6357305</ArticleId>
            <ArticleId IdType="pubmed">30787979</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35352622</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>31</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1744-5116</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>60</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pharmaceutical biology</Title>
          <ISOAbbreviation>Pharm Biol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>β-Hydroxyisovalerylshikonin regulates macrophage polarization <i>via</i> the AMPK/Nrf2 pathway and ameliorates sepsis in mice.</ArticleTitle>
        <Pagination>
          <StartPage>729</StartPage>
          <EndPage>742</EndPage>
          <MedlinePgn>729-742</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13880209.2022.2046111</ELocationID>
        <Abstract>
          <AbstractText Label="CONTEXT" NlmCategory="UNASSIGNED">The potential anti-inflammatory bioactivities of β-hydroxyisovalerylshikonin (β-HIVS) remain largely unknown.</AbstractText>
          <AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">This study investigated the anti-inflammatory effects and underlying mechanisms of β-HIVS.</AbstractText>
          <AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">RAW 264.7 cells stimulated with LPS (100 ng/mL) for 24 h were treated with the non-cytotoxic doses of β-HIVS (0.5 or 1 μM, determined by MTT and Trypan blue staining), qRT-PCR and FCM assay were used to examine macrophage polarization transitions. Western blotting was used to evaluate the activation of the AMPK/Nrf2 pathway. <i>In vivo</i>, C57BL/6 mice were randomly divided into vehicle control, LPS (10 mg/kg), and β-HIVS (2.5 mg/kg) combined with LPS (10 mg/kg) groups, blood samples, BALF, and lung tissues of mice were subjected to ELISA, qRT-PCR, FCM, and H&amp;E staining.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">β-HIVS (1 μM) inhibited LPS-induced expression of M1 macrophage markers (TNF-α: 0.29-fold, IL-1β: 0.32-fold), promoted the expression of M2 macrophage markers (CD206: 3.14-fold, Arginase-1: 3.98-fold) in RAW 264.7 cells; mechanistic studies showed that β-HIVS increased the expression of nuclear Nrf2 (2.04-fold) and p-AMPK (3.65-fold) compared with LPS group (<i>p</i> &lt; 0.05). <i>In vivo</i>, β-HIVS decreased the levels of pro-inflammatory cytokines (TNF-α: 1130.41 <i>vs.</i> 334.88 pg/mL, IL-1β: 601.89 <i>vs.</i> 258.21 pg/mL in serum; TNF-α: 893.07 <i>vs.</i> 418.21 pg/mL, IL-1β: 475.22 <i>vs.</i> 298.54 pg/mL in BALF), decreased the proportion of M1 macrophages (77.83 <i>vs.</i> 68.53%) and increased the proportion of M2 macrophages (13.55 <i>vs.</i> 19.56%) in BALF, and reduced lung tissue damage and septic mice survival (<i>p</i> &lt; 0.05).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">These results indicate that β-HIVS may be a new potential anti-inflammatory agent.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pan</LastName>
            <ForeName>Tao</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Translational Medicine Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shaanxi Key Laboratory of Brain Disorders, Institute of Basic Medical Sciences, Institute of Basic and Translational Medicine, Xi'an Medical University, Xi'an, Shaanxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Chang</LastName>
            <ForeName>Yabin</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Translational Medicine Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Min</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Translational Medicine Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>He</LastName>
            <ForeName>Zehui</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Translational Medicine Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jiang</LastName>
            <ForeName>Jun</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Xinling</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Carson International Cancer Center, Shenzhen University, Shenzhen, Guangdong, China.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Shenzhen University Clinical Medical Academy, Shenzhen, Guangdong, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Fang</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Respiratory Medicine, Xijing Hospital, Air Force Medical University, Xi'an, Shaanxi, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pharm Biol</MedlineTA>
        <NlmUniqueID>9812552</NlmUniqueID>
        <ISSNLinking>1388-0209</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D008070">Lipopolysaccharides</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051267">NF-E2-Related Factor 2</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D009285">Naphthoquinones</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C118460">beta-hydroxyisovalerylshikonin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.31</RegistryNumber>
          <NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008070" MajorTopicYN="N">Lipopolysaccharides</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008810" MajorTopicYN="N">Mice, Inbred C57BL</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051267" MajorTopicYN="Y">NF-E2-Related Factor 2</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009285" MajorTopicYN="N">Naphthoquinones</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018805" MajorTopicYN="Y">Sepsis</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Chinese herb extract</Keyword>
        <Keyword MajorTopicYN="N">anti-inflammatory effect</Keyword>
        <Keyword MajorTopicYN="N">lipopolysaccharide</Keyword>
        <Keyword MajorTopicYN="N">non‑cytotoxic dose</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
          <Hour>8</Hour>
          <Minute>39</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35352622</ArticleId>
        <ArticleId IdType="pmc">PMC8973340</ArticleId>
        <ArticleId IdType="doi">10.1080/13880209.2022.2046111</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Benoit M, Desnues B, Mege JL.. 
2008. Macrophage polarization in bacterial infections. J Immunol. 3733–3739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18768823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cho HY, Gladwell W, Wang X, Chorley B, Bell D, Reddy SP, Kleeberger SR.. 
2010. Nrf2-regulated PPAR{γ} expression is critical to protection against acute lung injury in mice. Am J Respir Crit Care Med. 182(2):170–182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2913232</ArticleId>
            <ArticleId IdType="pubmed">20224069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al. . 
2013. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 41(2):580–637.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23353941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dilshara MG, Karunarathne WAHM, Molagoda IMN, Kang C-H, Jeong J-W, Choi YH, Kim G-Y.. 
2018. β-Hydroxyisovalerylshikonin promotes reactive oxygen species production in HCT116 colon cancer cells, leading to caspase-mediated apoptosis. Rev Brasil Farmacog. 28(3):344–351.</Citation>
        </Reference>
        <Reference>
          <Citation>Ding H, Wang JJ, Zhang XY, Yin L, Feng T.. 
2021. Lycium barbarum polysaccharide antagonizes LPS-induced inflammation by altering the glycolysis and differentiation of macrophages by triggering the degradation of PKM2. Biol Pharm Bull. 44(3):379–388.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33390389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng L, Song P, Zhou H, Li A, Ma Y, Zhang X, Liu H, Xu G, Zhou Y, Wu X, et al. . 
2014. Pentamethoxyflavanone regulates macrophage polarization and ameliorates sepsis in mice. Biochem Pharmacol. 89(1):109–118.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24607272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feng LL, Xu LS, Guo MM, Huang W, Zhu JZ, Kong LD, Wu XD, Xu Q.. 
2019. 5,7,2′,4′,5′-Pentamethoxyflavanone regulates M1/M2 macrophage phenotype and protects the septic mice. Chin J Nat Med. 17(5):363–371.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31171271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fu J, Zang Y, Zhou Y, Chen C, Shao S, Hu M, Shi G, Wu L, Zhang D, Zhang T.. 
2020. A novel triptolide derivative ZT01 exerts anti-inflammatory effects by targeting TAK1 to prevent macrophage polarization into pro-inflammatory phenotype. Biomed Pharmacother. 126:110084.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">32171166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gordon S, Martinez FO.. 
2010. Alternative activation of macrophages: mechanism and functions. Immunity. 32(5):593–604.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">20510870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grivennikov SI, Greten FR, Karin M.. 
2010. Immunity, inflammation, and cancer. Cell. 140(6):883–899.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2866629</ArticleId>
            <ArticleId IdType="pubmed">20303878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo Y, Zhang Y, Hong K, Luo F, Gu Q, Lu N, Bai A.. 
2014. AMPK inhibition blocks ROS-NFκB signaling and attenuates endotoxemia-induced liver injury. PLOS One. 9(1):e86881.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3901729</ArticleId>
            <ArticleId IdType="pubmed">24475189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hashimoto S, Xu M, Masuda Y, Aiuchi T, Nakajo S, Cao J, Miyakoshi M, Ida Y, Nakaya K.. 
1999. β-Hydroxyisovalerylshikonin inhibits the cell growth of various cancer cell lines and induces apoptosis in leukemia HL-60 cells through a mechanism different from those of Fas and etoposide. J Biochem. 125(1):17–23.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9880790</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Joo MS, Kim WD, Lee KY, Kim JH, Koo JH, Kim SG.. 
2016. AMPK facilitates nuclear accumulation of Nrf2 by phosphorylating at serine 550. Mol Cell Biol. 36(14):1931–1942.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4936058</ArticleId>
            <ArticleId IdType="pubmed">27161318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li P, Wu Y, Li M, Qiu X, Bai X, Zhao X.. 
2015. AS-703026 inhibits LPS-induced TNFα production through MEK/ERK dependent and independent mechanisms. PLOS One. 10(9):e0137107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4575053</ArticleId>
            <ArticleId IdType="pubmed">26381508</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Niu X, Zhou W, Yi J.. 
2010. Growth inhibitory effect of β-hydroxyisovalerylshikonin on prostate cancer cells and related mechanism. J Shanghai Jiaotong Univ. 30:527–530.</Citation>
        </Reference>
        <Reference>
          <Citation>Livak KJ, Schmittgen TD.. 
2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCt Method. Methods. 25(4):402–408.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11846609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lu D, Qian J, Li W, Feng Q, Pan S, Zhang S.. 
2015. β-Hydroxyisovaleryl-shikonin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signaling. Oncol Lett. 10(6):3434–3442.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4665374</ArticleId>
            <ArticleId IdType="pubmed">26788147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luo W, Xu Q, Wang Q, Wu H, Hua J.. 
2017. Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease. Sci Rep. 7:44612.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5353732</ArticleId>
            <ArticleId IdType="pubmed">28300213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lv H, Liu Q, Wen Z, Feng H, Deng X, Ci X.. 
2017. Xanthohumol ameliorates lipopolysaccharide (LPS)-induced acute lung injury via induction of AMPK/GSK3β-Nrf2 signal axis. Redox Biol. 12:311–324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5345976</ArticleId>
            <ArticleId IdType="pubmed">28285192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ma WT, Gao F, Gu K, Chen DK.. 
2019. The role of monocytes and macrophages in autoimmune diseases: a comprehensive review. Front Immunol. 10:1140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6543461</ArticleId>
            <ArticleId IdType="pubmed">31178867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M.. 
2013. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 229(2):176–185.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23096265</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mantovani A, Sozzani S, Locati M, Allavena P, Sica A.. 
2002. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23(11):549–555.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12401408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masuda Y, Nishida A, Hori K, Hirabayashi T, Kajimoto S, Nakajo S, Kondo T, Asaka M, Nakaya K.. 
2003. β-Hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1). Oncogene. 22(7):1012–1023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12592388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masuda Y, Shima G, Aiuchi T, Horie M, Hori K, Nakajo S, Kajimoto S, Shibayama-Imazu T, Nakaya K.. 
2004. Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. J Biol Chem. 279(41):42503–42515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15292218</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mo C, Wang L, Zhang J, Numazawa S, Tang H, Tang X, Han X, Li J, Yang M, Wang Z, et al. . 
2014. The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid Redox Signal. 20(4):574–588.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3901384</ArticleId>
            <ArticleId IdType="pubmed">23875776</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan T, Zhang F, Li F, Gao X, Li Z, Li X, Ren X.. 
2020. Shikonin blocks human lung adenocarcinoma cell migration and invasion in the inflammatory microenvironment via the IL‑6/STAT3 signaling pathway. Oncol Rep. 44(3):1049–1063.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7388308</ArticleId>
            <ArticleId IdType="pubmed">32705271</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan T, Zhang M, Zhang F, Yan G, Ru Y, Wang Q, Zhang Y, Wei X, Xu X, Shen L, et al. . 
2017. NDRG2 overexpression suppresses hepatoma cells survival during metabolic stress through disturbing the activation of fatty acid oxidation. Biochem Biophys Res Commun. 483(2):860–866.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28069379</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu YL, Cheng XN, Bai F, Fang LY, Hu HZ, Sun DQ.. 
2018. Aucubin protects against lipopolysaccharide-induced acute pulmonary injury through regulating Nrf2 and AMPK pathways. Biomed Pharmacother. 106:192–199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29958143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saccani A, Schioppa T, Porta C, Biswas SK, Nebuloni M, Vago L, Bottazzi B, Colombo MP, Mantovani A, Sica A.. 
2006. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance. Cancer Res. 66(23):11432–11440.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17145890</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saha S, Buttari B, Panieri E, Profumo E, Saso L.. 
2020. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules. 25(22):5474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7700122</ArticleId>
            <ArticleId IdType="pubmed">33238435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schneider CA, Rasband WS, Eliceiri KW.. 
2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 9(7):671–675.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5554542</ArticleId>
            <ArticleId IdType="pubmed">22930834</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sica A, Mantovani A.. 
2012. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 122(3):787–795.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3287223</ArticleId>
            <ArticleId IdType="pubmed">22378047</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H, Hainzl A, Schatz S, Qi Y, Schlecht A, et al. . 
2011. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest. 121(3):985–997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3049372</ArticleId>
            <ArticleId IdType="pubmed">21317534</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Takai N, Ueda T, Nishida M, Nasu K, Narahara H.. 
2010. Anti-neoplastic effect of β-hydroxyisovalerylshikonin on a human choriocarcinoma cell line. Mol Med Rep. 3(3):515–518.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21472272</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wallmeyer L, Dietert K, Sochorová M, Gruber AD, Kleuser B, Vávrová K, Hedtrich S.. 
2017. TSLP is a direct trigger for T cell migration in filaggrin-deficient skin equivalents. Sci Rep. 7(1):774.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5428778</ArticleId>
            <ArticleId IdType="pubmed">28377574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang R, Yin R, Zhou W, Xu D, Li S.. 
2012. Shikonin and its derivatives: a patent review. Expert Opin Ther Pat. 22(9):977–997.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22834677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Huang Y, Xu Y, Ruan W, Wang H, Zhang Y, Saavedra JM, Zhang L, Huang Z, Pang T.. 
2018. A dual AMPK/Nrf2 activator reduces brain inflammation after stroke by enhancing microglia M2 polarization. Antioxid Redox Signal. 28(2):141–163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28747068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Xu Y, Zhang P, Ruan W, Zhang L, Yuan S, Pang T, Jia AQ.. 
2018. Smiglaside A ameliorates LPS-induced acute lung injury by modulating macrophage polarization via AMPK-PPARγ pathway. Biochem Pharmacol. 156:385–395.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30195731</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wei J, Chen G, Shi X, Zhou H, Liu M, Chen Y, Feng D, Zhang P, Wu L, Lv X.. 
2018. Nrf2 activation protects against intratracheal LPS induced mouse/murine acute respiratory distress syndrome by regulating macrophage polarization. Biochem Biophys Res Commun. 500(3):790–796.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29684352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wright CJ, Agboke F, Muthu M, Michaelis KA, Mundy MA, La P, Yang G, Dennery PA.. 
2012. Nuclear factor-κB (NF-κB) inhibitory protein IκBβ determines apoptotic cell death following exposure to oxidative stress. J Biol Chem. 287(9):6230–6239.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3307281</ArticleId>
            <ArticleId IdType="pubmed">22223647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wynn TA, Chawla A, Pollard JW.. 
2013. Macrophage biology in development, homeostasis and disease. Nature. 496(7446):445–455.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3725458</ArticleId>
            <ArticleId IdType="pubmed">23619691</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y, Kajimoto S, Nakajo S, Nakaya K.. 
2004. Beta-hydroxyisovalerylshikonin and cisplatin act synergistically to inhibit growth and to induce apoptosis of human lung cancer DMS114 cells via a tyrosine kinase-dependent pathway. Oncology. 66(1):67–75.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15031601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang F, Pan T, Wu X, Gao X, Li Z, Ren X.. 
2020. Non-cytotoxic doses of shikonin inhibit lipopolysaccharide-induced TNF-α expression via activation of the AMP-activated protein kinase signaling pathway. Exp Ther Med. 20(5):45.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7480124</ArticleId>
            <ArticleId IdType="pubmed">32952636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang JL, Xu Y, Shen J.. 
2014. Cordycepin inhibits lipopolysaccharide (LPS)-induced tumor necrosis factor (TNF)-α production via activating AMP-activated protein kinase (AMPK) signaling. Int J Mol Sci. 15(7):12119–12134.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4139833</ArticleId>
            <ArticleId IdType="pubmed">25007068</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang W, Zhang Y, He Y, Wang X, Fang Q.. 
2019. Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway. Exp Cell Res. 376(2):124–132.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30763585</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang X, Shang F, Hui L, Zang K, Sun G.. 
2017. The alleviative effects of metformin for lipopolysaccharide-induced acute lung injury rat model and its underlying mechanism. Saudi Pharm J. 25(4):666–670.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5447443</ArticleId>
            <ArticleId IdType="pubmed">28579909</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou F, Wang M, Ju J, Wang Y, Liu Z, Zhao X, Yan Y, Yan S, Luo X, Fang Y.. 
2019. Schizandrin A protects against cerebral ischemia-reperfusion injury by suppressing inflammation and oxidative stress and regulating the AMPK/Nrf2 pathway regulation. Am J Transl Res. 11(1):199–209.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6357305</ArticleId>
            <ArticleId IdType="pubmed">30787979</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
